Spearhead Capital Advisors, LLC Invitae Corp Transaction History

Spearhead Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$6.28 - $15.59 $75,498 - $187,422	-12,022 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$14.7 - $28.67 $17,948 - $35,006	1,221 Added 11.3%	12,022 $184,000
Q3 2021 Oct 27, 2021	BUY	$24.31 - $33.6 $16,846 - $23,284	693 Added 6.86%	10,801 $307,000
Q2 2021 Aug 10, 2021	BUY	$26.09 - $40.4 $44,431 - $68,801	1,703 Added 20.26%	10,108 $341,000
Q1 2021 Apr 28, 2021	SELL	$33.06 - $56.93 $137,926 - $237,511	-4,172 Reduced 33.17%	8,405 $321,000
Q4 2020 Feb 02, 2021	BUY	$39.09 - $57.4 $5,746 - $8,437	147 Added 1.18%	12,577 $526,000
Q3 2020 Oct 16, 2020	BUY	$28.43 - $44.67 $16,006 - $25,149	563 Added 4.74%	12,430 $539,000
Q2 2020 Jul 16, 2020	BUY	$11.71 - $30.29 $138,962 - $359,451	11,867 New	11,867 $359,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.